🔎 Trials Near Me

Pradžia › Transplantato atsakas į šeimininką › New Jersey

Transplantato atsakas į šeimininką klinikiniai tyrimai New Jersey

4 tyrimai dėl Transplantato atsakas į šeimininką ieško dalyvių vietose New Jersey.

Miestai New Jersey

Oficialus tyrimo tekstas (anglų kalba)

A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT07359859

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

  • John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-07 · NCT07216443

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale
Renkami dalyviai2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-06-29 · NCT07006506

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

  • Memorial Sloan Kettering at Basking Ridge (Consent only), Basking Ridge
  • Memorial Sloan Kettering Monmouth (Consent only), Middletown
  • Memorial Sloan Kettering Cancer Center @ Bergen (Consent only), Montvale
Renkami dalyviai2 fazė
Amžius 4 ir vyresni · Visoms lytims · Atnaujinta 2026-05-22 · NCT05675930

Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.